Literature DB >> 9768696

Cortisol, androstenedione (A4), dehydroepiandrosterone sulphate (DHEAS) and 17 hydroxyprogesterone (17OHP) responses to low doses of (1-24)ACTH.

N A Bridges1, P C Hindmarsh, P J Pringle, J W Honour, C G Brook.   

Abstract

The dose of 250 microg used in the standard short synacthen test is supraphysiological and lower doses may provide a more sensitive test. We examined steroid responses to 125ng/m2, 250ng/m2 and 500 ng/m2 (1-24)ACTH in 6 normal males, looking at effects of dose and the within- and between-subject coefficients of variation (CV). Subjects were given each dose 3 times, blood samples were taken at 10 minute intervals. There was a dose response relationship between dose of (1-24)ACTH and peak values for cortisol and 17OHP (p<0.05). There was no difference between peaks of A4 at different doses and no clear peaks were reached for DHEAS. 86% of the peaks for 17OHP, 63% for A4 and 25% for cortisol were at 10 minutes and 14%, 29% and 65% respectively at 20 mins (p=0.001). Within-subject CV for cortisol was 12.6% and between subject 10.1%. Tests of adrenal function using low doses of (1-24)ACTH have acceptable between- and within-subject CV for peak values with a dose as low as 125 ng/m2 (1-24)ACTH. Protocols for low dose synacthen tests, with traditional sampling at zero, 30 and 60 minutes or even as shown here at 10 minute intervals, fail to fully define the changes in steroid levels following adrenal stimulation. More frequent blood sampling will be needed to accurately detect peak levels in particular of 17OHP and A4.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768696     DOI: 10.1210/jcem.83.10.5315

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Clinical usefulness of the low dose ACTH test.

Authors:  L Patel; P E Clayton
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

Review 2.  The impact of hormone physiology on clinical practice with reference to two papers spanning 40 years of endocrinology.

Authors:  P C Hindmarsh
Journal:  Arch Dis Child       Date:  2005-11       Impact factor: 3.791

3.  Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.

Authors:  Robert L Rosenfield; Monica Mortensen; Kristen Wroblewski; Elizabeth Littlejohn; David A Ehrmann
Journal:  Hum Reprod       Date:  2011-09-09       Impact factor: 6.918

4.  Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease.

Authors:  G Aimaretti; C Baffoni; L Di Vito; S Grottoli; D Gaia; V Gasco; R Giordano; Z Zadik; F Camanni; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 5.  Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Authors:  George P Chrousos; Tomoshige Kino; Evangelia Charmandari
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

6.  Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index.

Authors:  Brian Bordini; Elizabeth Littlejohn; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.